Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

MK-5108 is safe and shows potential against tumors, especially alone.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Cancer treatments often cause skin, nail, and hair problems.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

CXCR2 in skin cells promotes tumor growth.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

The drug combination was safe and showed promise in treating advanced tumors.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.